Semaglutide select trial results

8 months. SELECT is the first cardiovascular outcomes trial to evaluate superiority in major adverse cardiovascular events reduction for an antiobesity medication in such a population

2024-03-19
    Lamictal and abortion pill
  1. November 11, 2023
  2. As
  3. 4 mg was associated with a statistically significant 20%
  4. About the SELECT trial
  5. 4 months